Although certainty of existing evidence was low, adverse events were uncommon and mild, supporting further high-quality clinical trials
Any part of your body can be affected, including your face and eyes, but the chest and tummy (abdomen) are the most common areas
Quick reference: retatrutide dosage chart This chart reflects the escalation schedule used in Phase 2 and Phase 3 clinical trials: Standard titration protocol (2mg start 12mg target) Alternative protocols by target dose Target: 8 mg maintenance Target: 4 mg maintenance Key principle: Start low, go slow
Patients whose only complaint is weight and who have no secondary concerns about skin, hair, inflammation, or tissue quality are better served by optimizing their GLP-1 protocol, adding resistance training, and addressing nutrition rather than adding a peptide that doesnt directly address their primary goal